Clinical Trial Update: Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is investigating whether the timing of stem cell infusion affects the development of acute graft-versus-host disease in patients with n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Anhui Provincial Hospital | Conditions: Acute Graft-versus-host Disease | Phase 3 | Status: RECRUITING